Status:
COMPLETED
dbGaP Protocol: The Pediatric Cardiac Genetics Consortium (PCGC)
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Congenital Heart Disease
Eligibility:
All Genders
Up to 60 years
Brief Summary
Background: Researchers do not know much about the causes of congenital heart disease (CHD). They do know that many factors play a role. Some factors are environmental. Some are genetic. But few spec...
Detailed Description
Current understanding of the causes of congenital heart disease (CHD) is limited, but CHD is known to be multifactorial and affected by a combination of environmental, teratogenic, and genetic causes....
Eligibility Criteria
Inclusion
- Retrospective Analysis Study. Data will be analyzed from subjects from cardiovascular disease databases.
Exclusion
Key Trial Info
Start Date :
October 20 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 10 2020
Estimated Enrollment :
6260 Patients enrolled
Trial Details
Trial ID
NCT03347214
Start Date
October 20 2017
End Date
January 10 2020
Last Update
January 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Heart, Lung and Blood Institute (NHLBI)
Bethesda, Maryland, United States, 20892